| Biological Sciences | Lifetime | 764 | CA 29 | 99.91 |
| Biological Sciences | 2021-2025 | 551 | CA 17 | 99.41 |
| Neuroscience of Neurology | Lifetime | 33 | CA 4 | 99.74 |
| Pathology and Forensic Medicine | Lifetime | 120 | CA 7 | 99.50 |
| Cancer Research | Lifetime | 231 | CA 12 | 98.66 |
| Developmental Neuroscience | Lifetime | 51 | CA 2 | 98.50 |
| Clinical Neurology | Lifetime | 400 | CA 21 | 98.33 |
| Immunology | Lifetime | 841 | CA 28 | 97.27 |
| Immunology and Allergy | Lifetime | 518 | CA 24 | 90.55 |
| Neuroscience of Neurology | 2021-2025 | 12 | CA 1 | 99.17 |
| Clinical Neurology | 2021-2025 | 64 | CA 6 | 98.75 |
| Pathology and Forensic Medicine | 2021-2025 | 118 | CA 8 | 97.28 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 28 | CA 4 | 99.85 |
| Protease and Inhibitor Mechanisms | Lifetime | 34 | CA 2 | 99.52 |
| Signaling Pathways in Disease | Lifetime | 23 | CA 1 | 99.51 |
| Immune cells in cancer | Lifetime | 70 | CA 5 | 99.49 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 52 | CA 2 | 99.61 |
| Multiple Sclerosis Research Studies | Lifetime | 67 | CA 5 | 99.51 |
| Immune Response and Inflammation | Lifetime | 217 | CA 12 | 99.41 |
| Nerve injury and regeneration | Lifetime | 108 | CA 10 | 99.17 |
| Peptidase Inhibition and Analysis | Lifetime | 265 | CA 8 | 98.87 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 95 | CA 7 | 99.04 |
| Cell Adhesion Molecules Research | Lifetime | 353 | CA 11 | 98.80 |
| Spinal Cord Injury Research | Lifetime | 316 | CA 48 | 96.70 |
| S100 Proteins and Annexins | Lifetime | 454 | CA 18 | 95.78 |
| interferon and immune responses | Lifetime | 763 | CA 21 | 95.81 |
| Peripheral Neuropathies and Disorders | Lifetime | 439 | CA 11 | 96.67 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 893 | CA 52 | 95.56 |
| Galectins and Cancer Biology | Lifetime | 746 | CA 29 | 94.04 |
| Proteoglycans and glycosaminoglycans research | Lifetime | 686 | CA 24 | 94.59 |
| RNA regulation and disease | Lifetime | 917 | CA 38 | 93.69 |
| Chemokine receptors and signaling | Lifetime | 567 | CA 17 | 93.10 |
| Inflammation biomarkers and pathways | Lifetime | 847 | CA 24 | 70.70 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 14 | CA 2 | 99.51 |
| Intracerebral and Subarachnoid Hemorrhage Research | 2021-2025 | 12 | CA 2 | 99.22 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 11 | CA 1 | 98.41 |
| Multiple Sclerosis Research Studies | 2021-2025 | 107 | CA 4 | 98.25 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 251 | CA 8 | 93.14 |
| Immune cells in cancer | 2021-2025 | 780 | CA 12 | 89.34 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 432 | CA 13 | 82.86 |
| Inflammasome and immune disorders | 2021-2025 | 823 | CA 17 | 82.99 |
| RNA regulation and disease | 2021-2025 | 548 | CA 17 | 76.84 |
| Cholesterol and Lipid Metabolism | 2021-2025 | 265 | CA 6 | 74.51 |
| Kruppel-like factors research | 2021-2025 | 243 | CA 9 | 74.54 |
| Proteoglycans and glycosaminoglycans research | 2021-2025 | 301 | CA 5 | 74.05 |
| Signaling Pathways in Disease | 2021-2025 | 275 | CA 5 | 69.31 |